Novel Sepsis Sub-phenotypes Based on Trajectories of Vital Signs
Key facts
- Who runs it
- Emory University
- Where
- Atlanta and Johns Creek, United StatesSee the 4 sites
- Trial code
- Status
- Completed
- People taking part
- 1,916 people enrolled
- Started
- 18 Sept 2025
- Ended
- 14 Jan 2026
- Type of study
- Observational
- Treatments tested
- Implementation and evaluation of a sepsis sub-phenotyping algorithm
- Record updated
- 23 February 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- All adults who present to the emergency department
Who cannot take part
- None
Where in United States
- Emory Hospital MidtownAtlanta, United States
- Emory Saint Joseph's HospitalAtlanta, United States
- Emory University HospitalAtlanta, United States
- Emory Johns Creek HospitalJohns Creek, United States
About the trial
What the trial wants to find out
Sepsis is a dysregulated host response to infection resulting in organ dysfunction. Over the past three decades, more than 30 pharmacological therapies have been tested in >100 clinical trials and have failed to show consistent benefit in the overall population of patients with sepsis. The one-size-fits-all approach has not worked. This has resulted in a shift in research towards identifying sepsis subphenotypes through unsupervised learning. The ultimate objective is to identify sepsis subphenotypes with different responses to therapies, which could provide a path towards the precision medicine approach to sepsis.
Read full original descriptionShow less
The investigators have previously discovered sepsis subphenotypes in retrospective data using trajectories of vital signs in the first 8 hours of hospitalization. The team aims to prospectively classify adult hospitalized patients into these subphenotypes in a prospective, observational study. This will be done through the implementation of an electronic health record integrated application that will use vital signs from hospitalized patients to classify the patients into one of four subphenotypes. This study will continue until 1,200 patients with infection are classified into the sepsis subphenotypes. The classification of the patients is only performed to validate the association of the subphenotypes with clinical outcomes as was shown in retrospective studies. Physicians and providers treating the patients will not see the classification, and the algorithm classifying the patients will in no way affect the care of the patients. Further, all the data needed for the algorithm (vital signs from the first 8 hours) are standard of care, and enrollment in the prospective study does not require any additional data.
Treatments tested
- Implementation and evaluation of a sepsis sub-phenotyping algorithm
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Implementation and Prospective Validation of a Sepsis Sub-phenotyping Algorithm Based on Vital Sign Trajectories
- Record updated
- 23 February 2026